Biotech · Public company · Rockville, MD, US
Maxcyte, Inc.
Ticker MXCT · SEC CIK 0001287098
Track this companyFree. Adds Maxcyte, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- CyclophosphamidePhase 1 · Peritoneal MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- MCY-M11Phase 1 · Peritoneal MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal MesotheliomaPHASE1 · TERMINATED · started Aug 27, 2018ClinicalTrials.gov NCT03608618 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 17, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 16, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 27, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 24, 2026 · fetched Nov 12, 2026